Abstract
Nat. Med.; 10.1038/nm.4281; corrected online 15 February 2017 In the version of this article initially published online, Yves De Koninck's name was misspelled in the author list. The original version listed Yves DeKoninck. The error has been corrected in the print, PDF and HTML versions of this article.
Highlights
In the version of this article initially published, the western blot in Figure 2a for the BT474 cell line was incorrect
In the version of this article initially published, the Acknowledgements section contained an error: “The WEBs laboratory is supported by the Deutsche Forschungsgemeinschaft grant DFG EXC 1003 (H.S.).” is incorrect
The error has been corrected in the HTML and PDF versions of the article
Summary
In the version of this article initially published, the western blot in Figure 2a for the BT474 cell line was incorrect. Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia 23, 250–255 (2017); published online 19 December 2016; corrected after print 18 April 2017
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have